The purpose of this survey is to quantify the time from symptom onset to diagnosis and correlate potential delays with challenges associated with diagnosis experienced by amyloidosis patients with multiple myeloma, in partnership with Morie Gertz, MD, Mayo Clinic, Sascha Tuchman, MD, University of North Carolina at Chapel Hill, Aman Godara, MBBS, Huntsman Cancer Institute Jeffrey Zonder, MD, Karmanos Cancer Institute Giada Bianchi, MD, Harvard Institute of Medicine Heather J. Landau, MD, Memorial Sloan Kettering Cancer Center James Hoffman, MD, Sylvester Comprehensive Cancer Center

For any questions or concerns regarding the study, participants can contact HealthTree Patient Navigators at support@healthtree.org.